Assenagon Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $649K | Sell |
|
|||||
|
2025
Q2 | $804K | Sell |
|
|||||
|
2025
Q1 | $622K | Sell |
|
|||||
|
2024
Q4 | $1.11M | Buy |
|
|||||
|
2024
Q3 | $1.49M | Sell |
|
|||||
|
2024
Q2 | $5.53M | Sell |
|
|||||
|
2024
Q1 | $10.2M | Hold |
|
|||||
|
2023
Q4 | $5.49M | Sell |
|
|||||
|
2023
Q3 | $7.06M | Buy |
|
|||||
|
2023
Q2 | $1.89M | Sell |
|
|||||
|
2023
Q1 | $4.79M | Buy |
|
|||||
|
2022
Q4 | $2.44M | Buy |
|
|||||
|
2022
Q3 | $1.2M | Sell |
|
|||||
|
2022
Q2 | $6.49M | Buy |
|
|||||
|
2022
Q1 | $9.62M | Buy |
|
|||||
|
2021
Q4 | $8.34M | Buy |
|
|||||
|
2021
Q3 | $5.41M | Buy |
|
|||||
|
2021
Q2 | $720K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $6.24M | Buy |
|
|||||
|
2020
Q2 | $2.45M | Buy |
|